11-31594824-G-T
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_019040.5(ELP4):c.436G>T(p.Val146Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000406 in 1,550,366 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019040.5 missense
Scores
Clinical Significance
Conservation
Publications
- aniridia 2Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Genomics England PanelApp
- aniridia 1Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELP4 | NM_019040.5 | c.436G>T | p.Val146Leu | missense_variant | Exon 4 of 10 | ENST00000640961.2 | NP_061913.3 | |
ELP4 | NM_001288726.2 | c.436G>T | p.Val146Leu | missense_variant | Exon 4 of 12 | NP_001275655.1 | ||
ELP4 | NM_001288725.2 | c.436G>T | p.Val146Leu | missense_variant | Exon 4 of 11 | NP_001275654.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152092Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000548 AC: 11AN: 200660 AF XY: 0.0000363 show subpopulations
GnomAD4 exome AF: 0.0000172 AC: 24AN: 1398156Hom.: 0 Cov.: 27 AF XY: 0.0000159 AC XY: 11AN XY: 693578 show subpopulations
GnomAD4 genome AF: 0.000256 AC: 39AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.000349 AC XY: 26AN XY: 74414 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.436G>T (p.V146L) alteration is located in exon 4 (coding exon 4) of the ELP4 gene. This alteration results from a G to T substitution at nucleotide position 436, causing the valine (V) at amino acid position 146 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at